The objective of non-inferiority trials is to demonstrate the efficiency of a novel treatment whether it is acceptably less or more efficient than a control or active (existing) treatment. They are employed in situations where, when compared to the active treatment, the novel treatment is to be advantageous with higher rates of reliability, compatibility, cost-efficiency, etc. Odds ratio is the most significant measure used in investigating the size of efficiency of treatments relative to one another. The purpose of the study is to calculate and evaluate the sample size under different scenarios based on three different test statistics in non-inferiority trials for one proportion via Monte Carlo simulations
Thesis (Master's)--University of Washington, 2015-12In clinical trials, the comparison of binary out...
Bayesian analysis of a non-inferiority trial is advantageous in allowing direct probability statemen...
The three-arm non-inferiority trials include an experimental treatment arm, an active comparator arm...
Background: It is never easy to make sample size calculation for two-arm, non-inferiority st...
In the previous educational articles, we explained how to calculate the sample size for a rate or a ...
In the previous educational articles, we explained how to calculate the sample size for a rate or a ...
Contains fulltext : 57330.pdf (publisher's version ) (Closed access)In clinical tr...
A sample size justification is a vital part of any trial design. However, estimating the number of p...
This paper presents an approximate closed form sample size formula for determining non-inferiority i...
This paper presents an approximate closed form sample size formula for determining non-inferiority i...
Background Non-inferiority trials are performed when the main therapeutic effect of the new therapy ...
Background The size of the margin strongly influences the required sample size in non-inferiority an...
<p>Success rate ranging 60–90%; exclusions ranging 0–25%; non-inferiority margin (delta) 6%, 8% and ...
The concept of assurance in the two-arm non-inferiority trials has been explored, expressing the non...
In the previous educational articles, we explained how to calculate the sample size for a rate or a ...
Thesis (Master's)--University of Washington, 2015-12In clinical trials, the comparison of binary out...
Bayesian analysis of a non-inferiority trial is advantageous in allowing direct probability statemen...
The three-arm non-inferiority trials include an experimental treatment arm, an active comparator arm...
Background: It is never easy to make sample size calculation for two-arm, non-inferiority st...
In the previous educational articles, we explained how to calculate the sample size for a rate or a ...
In the previous educational articles, we explained how to calculate the sample size for a rate or a ...
Contains fulltext : 57330.pdf (publisher's version ) (Closed access)In clinical tr...
A sample size justification is a vital part of any trial design. However, estimating the number of p...
This paper presents an approximate closed form sample size formula for determining non-inferiority i...
This paper presents an approximate closed form sample size formula for determining non-inferiority i...
Background Non-inferiority trials are performed when the main therapeutic effect of the new therapy ...
Background The size of the margin strongly influences the required sample size in non-inferiority an...
<p>Success rate ranging 60–90%; exclusions ranging 0–25%; non-inferiority margin (delta) 6%, 8% and ...
The concept of assurance in the two-arm non-inferiority trials has been explored, expressing the non...
In the previous educational articles, we explained how to calculate the sample size for a rate or a ...
Thesis (Master's)--University of Washington, 2015-12In clinical trials, the comparison of binary out...
Bayesian analysis of a non-inferiority trial is advantageous in allowing direct probability statemen...
The three-arm non-inferiority trials include an experimental treatment arm, an active comparator arm...